Camp Lejeune $330 Trillion Claims Figure: What DOJ Told the Court and Why It Isn't What Will Be Paid
A Justice Department lawyer cited the $330 trillion face value of Camp Lejeune claims in closing the second bellwether bench trial. The figure is the sum of amounts claimants wrote on their forms, not a liability estimate, and roughly $879 million has actually been paid.
Torts Desk··14 min read

The Camp Lejeune $330 trillion figure is the Justice Department's tally of the dollar amounts that roughly 408,000 claimants wrote on their administrative claims, and a government lawyer used it in closing arguments in David Fancher's kidney cancer bench trial, which ended on November 10, 2026. It is not an estimate of what the United States owes or will pay: as of September 18, 2026 the government had offered a little more than $1.1 billion and paid more than $879 million, and the Congressional Budget Office's original score for the Camp Lejeune Justice Act was about $6.1 billion over ten years.
The number matters anyway. It surfaced in a courtroom where Judge Terrence W. Boyle is weighing the first two trials under the Camp Lejeune Justice Act, it has been repeated in government press releases since at least March 2026, and it frames how Congress, the court and the public think about the size of the problem at the moment the Justice Department is asking the court to impose a Lone Pine Order on the docket. This article explains where the Camp Lejeune $330 trillion number comes from, why it is so large, how it compares with what has been paid, what happened in the Fancher trial, and what the figure does and does not change for claimants and their counsel.
What is the $330 trillion Camp Lejeune figure?
The $330 trillion Camp Lejeune figure is the aggregate "face value" of the administrative claims filed with the Department of the Navy under the Camp Lejeune Justice Act: the sum of every dollar amount claimants stated on their claim forms, added together without any adjustment for merit, documentation, causation or duplication.
The Justice Department first put a number of this size into public circulation in its March 10, 2026 press release announcing that it had approved 649 Elective Option offers worth $175 million in three weeks. That release stated that the estimated face value of claims submitted to the Navy "exceeds $335 trillion." Earlier, according to Bloomberg Law, Justice Department lawyers had told the court in a filing that the claims already topped $3 trillion. The figure has therefore moved by a factor of roughly one hundred as more claims were entered and valued, and it has been quoted at $330 trillion and $335 trillion in different settings since.
Divide $330 trillion by about 408,000 claims and the average comes to roughly $809 million per claim, the arithmetic Public Radio East used in its November 16 report. Using the March figure of $335 trillion and the 408,860 claims on file at the August 2024 deadline gives an average of about $819 million. Either way, the average is several hundred times larger than any payment the government has made under its fast-track program, and larger than most verdicts in American tort history.
Who said Camp Lejeune claims total $330 trillion, and where?
Justice Department trial attorney Jonathan Guynn cited the $330 trillion figure during closing arguments in Fancher v. United States, the second trial under the Camp Lejeune Justice Act, held before Judge Boyle in Elizabeth City, North Carolina. According to Public Radio East, Guynn used the number to defend the government's spending on expert witnesses and to emphasize the financial stakes of the litigation.
Plaintiffs' counsel objected to its use. In rebuttal on November 10, attorney Roberts told Judge Boyle that Guynn had cited the $330 trillion figure repeatedly, including in earlier proceedings in Wilmington. The point of the rebuttal was that a headline number describing the whole claim pool says nothing about whether one Marine veteran's kidney cancer was caused by the base's water, which is the only question the court had to decide in Fancher's case.
Advocates who have followed the litigation since its inception were blunter. Mike Partain and Jerry Ensminger, two of the most prominent voices for exposed Marines and families, described the figure as a "ridiculous" attempt to turn members of Congress against the victims. Partain also remarked that the total resembled the world's combined debt, a comparison that captures how far the number sits from any plausible liability.
Is the government really facing $330 trillion in Camp Lejeune claims?
No. The government is not facing $330 trillion in real exposure, because face value measures what claimants asked for on a form, not what the statute permits them to recover or what the court is likely to award. Several features of the Camp Lejeune Justice Act and the litigation make the realistic number orders of magnitude smaller.
The statute caps the forms of recovery. Section 804 of the Honoring our PACT Act bars Punitive Damages against the United States, and any award is offset by disability payments and benefits already provided by the government in connection with exposure at the base. The court has held that the government must prove such benefits were paid for a water-caused condition before an offset applies, but the offset still nets recoveries against the veterans' benefits system.
Most claims cannot yet be documented. In the November 9, 2026 joint status report, the parties told the court that more than 95% of claims reviewed by the Navy lacked sufficient documentation to qualify for the Elective Option. That is not a denial rate, but it means most of the face value sits in files that cannot presently support payment.
Many claims are duplicates or derivative. The administrative claim count includes family members, estates and multiple claims for the same exposure. Face value adds every one of them in full.
Causation still has to be shown. The statute requires evidence that a causal relationship is "at least as likely as not," a relaxed standard, but a real one. Claims for conditions outside the Agency for Toxic Substances and Disease Registry's assessments will need expert support for General Causation and Specific Causation.
The Congressional Budget Office's 2022 score, as reported by Bloomberg Law, projected Camp Lejeune payouts of about $6.1 billion over ten years. Even if that estimate proves badly low, the realistic range is measured in billions or tens of billions, not hundreds of trillions.
Why are Camp Lejeune claims valued so high?
Camp Lejeune claims carry enormous face values chiefly because of how federal administrative claims are written. A claim against the United States is presented on Standard Form 95, which asks the claimant to state a "sum certain" for the injury. Under the Federal Tort Claims Act presentment rule in 28 U.S.C. § 2675(b), a claimant who later sues generally cannot recover more than the amount stated in the administrative claim, except on the basis of newly discovered evidence or intervening facts. The Camp Lejeune Justice Act requires claimants to present their claims to the Navy before filing suit, so claimants' counsel had a strong incentive to state high figures to preserve the full range of possible damages.
The incentive was amplified by the claim-filing environment. The statute opened a two-year window, which closed in August 2024, and hundreds of thousands of claims were filed, many through firms that recruited claimants through national advertising. When every claimant chooses a ceiling rather than an estimate, and some choose ceilings in the billions, the aggregate becomes detached from any measure of loss. A handful of very large stated sums can account for a large share of the total.
This is why plaintiffs' advocates call the figure misleading and why the government's use of it in a bench trial drew an objection. The number tells the court and the public how much claimants protected on paper. It does not tell anyone how many claims are valid, how many have documented diagnoses, or what a court-supervised Settlement Matrix would pay for each disease.
Camp Lejeune $330 trillion versus what is actually paid: the numbers side by side
The gap between the headline figure and the money that has moved is the core of the story. The table below sets out each publicly reported figure and what it measures.
| Figure | Amount | What it measures | Source and date |
|---|---|---|---|
| Face value cited at Fancher trial | $330 trillion | Total of sums stated on administrative claims | DOJ closing argument, reported Nov. 16, 2026 |
| Face value in DOJ release | More than $335 trillion | Same measure, earlier statement | DOJ press release, Mar. 10, 2026 |
| Earlier DOJ court figure | More than $3 trillion | Claim totals at an earlier stage | DOJ court filing, reported by Bloomberg Law |
| Implied average per claim | About $809 million | $330 trillion divided by ~408,000 claims | Calculation reported by Public Radio East |
| CBO projected cost | About $6.1 billion over 10 years | Budget estimate of outlays | CBO score, reported by Bloomberg Law |
| Settlement offers made | More than $1.1 billion | Offers extended, mostly Elective Option | DOJ figures as of Sept. 18, 2026 |
| Payments made | More than $879 million | Money actually paid to claimants | DOJ figures as of Sept. 18, 2026 |
Put another way, the government has paid less than one-thousandth of one percent of the claimed face value. That ratio is not evidence that claimants have been shortchanged or that the government is overpaying; it is evidence that face value is the wrong yardstick for either argument.
How much has the government actually paid Camp Lejeune claimants?
The government had paid more than $879 million and offered more than $1.1 billion in Camp Lejeune settlements as of September 18, 2026, according to Justice Department figures. Nearly all of that money moved through the Elective Option, the voluntary program that pays fixed amounts based on the claimant's diagnosis tier and the length of time spent at the base, without case-by-case proof of causation.
The pace has accelerated in 2026. The Justice Department's March 10 release reported 649 offers worth $175 million approved over three weeks, more than $708 million in Elective Option offers approved since the program began in 2023 across 2,531 offers, and more than $421 million paid since January 20, 2025. A September 14 notice to the court reported 3,901 approved Elective Option offers worth about $1.084 billion.
Measured against the claimant pool, the payouts remain small. Fewer than 4,000 approved offers against more than 400,000 administrative claims means well under 1% of claimants had been paid through the fast track by the fall of 2026. WECT reported in March that one lawyer representing about 300 clients said only eight had received settlement money. The money is paid from the Judgment Fund, the permanent appropriation in 31 U.S.C. § 1304 that pays judgments and settlements against the United States, so payments do not require a new appropriation from Congress. That is one reason the political framing of the claim total matters: the Judgment Fund is not capped, and figures like $330 trillion invite calls for legislative limits.
What happened in the second Camp Lejeune trial?
The second Camp Lejeune Justice Act trial, Marine veteran David Fancher's kidney cancer case, was tried to Judge Boyle without a jury beginning November 9, 2026 and concluded on November 10. It was short because Judge Boyle ruled beforehand that scientific testimony and exhibits from the first trial, Mousser v. United States, could be used in Fancher's case, so the parties did not have to re-present the general science of trichloroethylene (TCE) and kidney cancer. Fancher's team was still allowed to present evidence about his own exposure, diagnosis and damages.
Both trials are bench trials because the court earlier rejected claimants' demands for juries; the judge acts as fact-finder. Both are part of the court's Track 1 bellwether process, which tests the diseases with the strongest scientific support first. Fancher's case was tried as a Bellwether Trial in the same sense used in multidistrict litigation, although the Camp Lejeune docket is not an MDL: the statute gives the Eastern District of North Carolina exclusive jurisdiction, and the cases are managed on a master docket by four judges.
The science dispute was the backdrop. On the day the Fancher trial opened, retired federal scientist Frank Bove, who worked on Camp Lejeune health studies at ATSDR, publicly challenged the government's kidney cancer defense, according to WUNC. Bove said the evidence linking TCE to kidney cancer is strong, pointing to studies of industrial workers, and defended ATSDR's design of comparing Marines at Camp Lejeune with Marines at Camp Pendleton, which he said helped account for factors such as smoking and alcohol use. The Justice Department relies in part on a federal incidence study that did not find a statistically significant increase in kidney cancer in that comparison, and argues that a general association does not prove causation in an individual case. In Mousser, it also argued that an upper-tract cancer of the renal pelvis should not automatically be treated as the "kidney cancer" the science addresses.
When will the judge rule in the Camp Lejeune trials?
No ruling date has been set in either Camp Lejeune trial. The Mousser trial ended on October 28, 2026, and the parties disagreed over the deadline for proposed findings of fact and conclusions of law: Mousser's lawyers asked for November 6, while the Justice Department asked for December 4, citing its preparation for Fancher. Judge Boyle will decide each case after those post-trial submissions, under Federal Rule of Civil Procedure 52, with written findings.
That means the earliest realistic window for a decision in Mousser is December 2026 or early 2027, with Fancher likely to follow on a similar schedule. Once judgment enters, either side may move to amend findings within 28 days and, because the United States is a party, has 60 days to appeal to the Fourth Circuit. A first appellate answer on how to apply the "at least as likely as not" standard is unlikely before late 2027.
Does the $330 trillion figure affect Camp Lejeune settlement amounts?
The $330 trillion figure does not set or cap any Camp Lejeune settlement amount; Elective Option payments are fixed by diagnosis tier and time on base, and any Global Settlement would be built on a disease-by-disease matrix, not on the sums claimants wrote on their forms. But the figure can influence settlement indirectly, in three ways.
It supports the government's push to shrink the denominator. The Justice Department's October 23 motion asks the court to enter a Lone Pine Order requiring plaintiffs to produce proof of exposure, diagnosis and, for some diseases, expert causation support. A claim pool presented as worth hundreds of trillions makes the argument for screening sound more urgent, even though the actual dispute is about documentation, not dollar amounts.
It shapes the political environment. The number appears in press releases and in arguments addressed to the public. Advocates' concern is that it will be used to resist legislative fixes, such as bills that would allow jury trials or broaden venue, and to justify tighter limits on fees.
It hardens negotiating positions. Settlement talks before court-appointed masters missed the court's October 30 target for a global framework. Rhetoric about trillions on one side and charges of delay on the other make the compromise on how many claims will be paid, and at what values, harder to reach.
The plaintiffs' answer to the Lone Pine motion is a claimant census, a Census Registry of the kind used in mass torts to collect basic data on every claim, focused on 25 conditions. Both motions remain pending; the court's November 16 hearing in Wilmington addressed the related fight over access to Marine Corps records, which the court reportedly took under advisement. A census would produce a defensible count of documented claims by disease; that number, not the face value, is what a settlement matrix would be built on.
What it means for claimants, plaintiffs' firms and funders
For claimants. The $330 trillion number has no bearing on what an individual claimant can recover. What matters is diagnosis, documentation of at least 30 days on the base between August 1, 1953 and December 31, 1987, and, for diseases outside the Elective Option tiers, expert support. Claimants who have not responded to Navy deficiency notices are at greater risk than any headline figure suggests.
For plaintiffs' firms. Inflated sum-certain figures were a rational hedge under § 2675(b), but they now carry a cost: they give the government a public talking point and may invite scrutiny of how claims were valued and signed up. Firms carrying large inventories should expect a Lone Pine or census order in some form and should be assembling diagnosis and exposure proof now. Inventory audits by disease subtype, such as renal cell carcinoma versus upper tract urothelial carcinoma, are the practical response to the government's trial strategy.
For litigation funders and lenders. Portfolio valuations that rely on claimed amounts are meaningless. The relevant inputs are the share of an inventory that can satisfy Elective Option documentation (which the status report suggests is small), the outcome of Mousser and Fancher on causation and offsets, and the timetable for any matrix. Funders exposed to Camp Lejeune should model a long tail.
For the Justice Department. Citing face value has rhetorical force but legal risk. In a bench trial, the judge decides a single claimant's case on the evidence; appeals to aggregate stakes can look like an argument from consequences. The government's stronger ground is the documentation record and the causation science, and the court's eventual findings in the two kidney cancer cases will matter far more to the program's cost than any aggregate figure.
Frequently asked questions
What is the Camp Lejeune $330 trillion figure?
It is the total of the dollar amounts that claimants stated on roughly 408,000 administrative claims filed with the Navy under the Camp Lejeune Justice Act. The Justice Department has called it the claims' "face value" and put it at more than $335 trillion in March 2026.
Who cited the $330 trillion figure in court?
Justice Department trial attorney Jonathan Guynn cited it in closing arguments in Fancher v. United States, the second Camp Lejeune Justice Act trial, before Judge Terrence W. Boyle in the Eastern District of North Carolina; the trial ended November 10, 2026.
Is the government really liable for $330 trillion?
No. Face value reflects claimants' stated ceilings, not liability. The Congressional Budget Office projected about $6.1 billion in costs over ten years, and the government had paid more than $879 million as of September 18, 2026.
Why did claimants list such large amounts?
Federal administrative claims require a "sum certain," and under 28 U.S.C. § 2675(b) a claimant generally cannot later sue for more than that amount, so many claimants stated high figures to preserve their full damages.
How much has the Camp Lejeune settlement program paid?
More than $879 million had been paid and more than $1.1 billion offered as of September 18, 2026, almost entirely through the Elective Option.
When will the Camp Lejeune trial rulings come out?
No date has been set. Post-trial findings in Mousser were contested between November 6 and December 4 deadlines, so rulings in Mousser and Fancher are unlikely before December 2026 and could come in early 2027.
Published for legal professionals. Analysis and summaries only — not legal advice, and no attorney-client relationship is created by use of this site.
Read next

Second Camp Lejeune Trial: Judge Carries Mousser Science Into Fancher Kidney Cancer Case Set for Nov. 9
The second Camp Lejeune trial, Fancher v. United States, opens November 9 with Judge Terrence Boyle letting the Mousser trial's scientific testimony and exhibits carry over. The first case still has no ruling, and the parties disagree on whether post-trial findings are due November 6 or December 4.
Torts Desk · 24 min

Camp Lejeune Settlement Update: Navy Says 95% of Reviewed Claims Lack Elective Option Documentation
A November 9 joint status report says more than 95% of Camp Lejeune claims the Navy has reviewed lack the paperwork for an Elective Option payout, up from 75% in October, as a fight over 100 million pages of military records and a November 16 hearing frame the next phase.
Torts Desk · 23 min

Camp Lejeune Trial Verdict Pending: Mousser Case Ends in Three Days as October 30 Settlement Target Passes
The first Camp Lejeune trial, Mousser v. United States, closed on October 28, 2026 with no ruling date from Judge Terrence W. Boyle. The Marine seeks about $1.2 million in economic damages; the government says he cannot prove causation and wants benefits offset.
Torts Desk · 23 min